Ann Neurol

1. PIRRONELLO M, Picozza M, Guerrera G, Corbisiero S, et al
   From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis.
   Ann Neurol. 2026 Jun 18. doi: 10.1002/ana.78277.
   

   >> Share

   
   
2. FRISELL T, Hedberg S, Piehl F
   Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study.
   Ann Neurol. 2026 Jun 17. doi: 10.1002/ana.78286.
   

   >> Share

   
   
3. BEHRENS M, Terroba-Navajas P, Willemse EAJ, Schadelin S, et al
   Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis.
   Ann Neurol. 2026 Jun 17. doi: 10.1002/ana.78285.
   

   >> Share

   
   
4. PANTULIANO MC, Arlt FA, Arenson N, Basuroski ID, et al
   Gephyrin Neurological Autoimmunity.
   Ann Neurol. 2026 Jun 17. doi: 10.1002/ana.78278.
   

   >> Share

   
   

   
   BMC Neurol

5. DOUDEIN M, Doudin SM, Lahlouh RA, Omarya O, et al
   Diagnostic and therapeutic challenges in anti-NMDA receptor encephalitis associated with an ovarian immature teratoma.
   BMC Neurol. 2026;26:401.
   

   >> Share

   
   
6. CANNEVA S, De Giovanni A, Pagella F, Trompetto C, et al
   Exacerbation of myasthenia gravis after zoledronic acid and denosumab: a novel clinical observation with therapeutic implications.
   BMC Neurol. 2026 Jun 18. doi: 10.1186/s12883-026-05036.
   

   >> Share

   
   
7. JARDINE RE, Kuznetsova V, D'Aprano F, Kalinicik T, et al
   The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis.
   BMC Neurol. 2026 Jun 17. doi: 10.1186/s12883-026-05085.
   

   >> Share

   
   
8. MORADI A, Ebrahimian A, Talebi M, Naseri A, et al
   The association between depressive symptoms and sleep quality in patients with multiple sclerosis: a systematic review and meta-analysis.
   BMC Neurol. 2026 Jun 15. doi: 10.1186/s12883-026-05075.
   

   >> Share

   
   

   
   Curr Opin Immunol

9. MOUTSOPOULOS HM, Cinoku II, Mavragani CP
   Raynaud's phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancy.
   Curr Opin Immunol. 2026;101:102803.
   

   >> Share

   
   

   
   Diabet Med

10. RICHARDSON E, Stribling B, Ridgeway J, Kitching-Davis C, et al
    A consensus statement on a National Competency Framework for training and assessment of knowledge and skills in diabetes technologies, including hybrid closed loop (HCL), insulin pump systems, and continuous glucose monitoring (CGM) devices.
    Diabet Med. 2026 Apr 6:e70253. doi: 10.1111/dme.70253.
    

    >> Share

    
    
11. DIAS RP, Marcovecchio ML, Willemsen RH, Campbell F, et al
    Considerations for the clinical use of teplizumab in stage 2 Type 1 diabetes: A Consensus Statement from the British Society of Paediatric Endocrinology and Diabetes (BSPED) and the Association of British Clinical Diabetologists (ABCD).
    Diabet Med. 2026 Apr 29:e70329. doi: 10.1111/dme.70329.
    

    >> Share

    
    
12. LIN Q, Zhou Y, Lei M, Ling P, et al
    Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Diabet Med. 2026 May 10:e70354. doi: 10.1111/dme.70354.
    

    >> Share

    
    
13. STOCKER R, Russell S, Taylor GS, Witham MD, et al
    What barriers need to be removed to incorporate resistance exercise into the lives of older adults with long-term diabetes and prefrailty? A deductive framework analysis using the Capability, Opportunity, Motivation and Behaviour (COM-B) behavioural s
    Diabet Med. 2026 May 16:e70367. doi: 10.1111/dme.70367.
    

    >> Share

    
    
14. METGHALCHI S, Bonnet-Serrano F, Alexandre L, Daclin S, et al
    Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion.
    Diabet Med. 2026 May 22:e70371. doi: 10.1111/dme.70371.
    

    >> Share

    
    
15. TONGA E, Evans M, Oliver N, Ng SM, et al
    Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio-economic areas.
    Diabet Med. 2026 Mar 29:e70304. doi: 10.1111/dme.70304.
    

    >> Share

    
    
16. BIBBY BM, Bach E, Christensen M, Fisker S, et al
    Sampling duration matters: Intraindividual variation of glycaemic metrics in type 1 diabetes using automated insulin delivery.
    Diabet Med. 2026 Mar 19:e70272. doi: 10.1111/dme.70272.
    

    >> Share

    
    
17. NARAYANAN S, Baker J, Welsh JB, Cappon G, et al
    Feasibility and benefits of continuous glucose monitoring for type 1 diabetes in Rwanda: A real-world 12-month continuation phase.
    Diabet Med. 2026 Mar 9:e70284. doi: 10.1111/dme.70284.
    

    >> Share

    
    

    
    Diabetes Res Clin Pract

18. SHAPIRA A, Penman MC, Schneider S, Adam A, et al
    A mobile device-based ecological momentary assessment in adolescents and young adults with diabetes: a systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2026;237:113302.
    

    >> Share

    
    

    
    Intern Med

19. KUDO A, Yaguchi H, Watanabe M, Nomura T, et al
    Association between the peptide spectrum match values of LGI1, ADAM22, ADAM23 and DLG4 in the immunoprecipitation products of five autoimmune encephalitis cases with LGI1 antibody: A case series.
    Intern Med. 2026 Jun 18. doi: 10.2169/internalmedicine.6503.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

20. PRAHALAD P, Zaharieva D, Maahs D
    Diabetes Technology: An Update.
    J Clin Endocrinol Metab. 2026 Apr 13:dgag164. doi: 10.1210.
    

    >> Share

    
    
21. LUNATI ME, Cimino V, Bernasconi D, Romano C, et al
    The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.
    J Clin Endocrinol Metab. 2026;111:1842-1849.
    

    >> Share

    
    
22. AHMADI S, Kotwal A, Bikas A, Altshuler BF, et al
    Utility of Genomic Sequencing Classifier in Managing Cytologically Indeterminate Oncocytic Thyroid Nodules.
    J Clin Endocrinol Metab. 2026 Feb 6:dgag044. doi: 10.1210.
    

    >> Share

    
    
23. LIGUORO I, D'Agostini M, Franco F, Martini G, et al
    Thyroid-Joint Crosstalk: A Systematic Review and Meta-Analysis of Thyroid Autoimmunity and Dysfunction in Juvenile Idiopathic Arthritis.
    J Clin Endocrinol Metab. 2026 Jun 17:dgag238. doi: 10.1210.
    

    >> Share

    
    

    
    J Neuroimmunol

24. WU Q, Li J, Li H, Kan H, et al
    Intestinal flora and metabolite changes: Uncovering pathogenic mechanisms in myasthenia gravis.
    J Neuroimmunol. 2026;419:578996.
    

    >> Share

    
    

    
    J Neurol

25. WILLEMS S, D'hooghe MB, Sastre-Garriga J, Pareto D, et al
    Spinal cord reserve is associated with multi-dimensional clinical resilience in multiple sclerosis.
    J Neurol. 2026;273:402.
    

    >> Share

    
    

    
    J Rheumatol

26. LECLAIR V, Berger C, Bouchard-Marmen M, Bourre-Tessier J, et al
    Does the ACR/EULAR Total Improvement Score reflect how individuals with autoimmune inflammatory myopathies feel and function?
    J Rheumatol. 2026 Jun 15:jrheum.2026-0046. doi: 10.3899/jrheum.2026-0046.
    

    >> Share

    
    
27. GARCIA-ESCUDERO P, Iturricha Ochoa de Echaguen A, Beltran de Otalora Garcia S, Lopez I Gomez M, et al
    Uncharted Territory: Adult-Onset Autoinflammatory Syndrome With a Newly Identified Mutation in the Coatomer WD-Associated Region of COPA Gene.
    J Rheumatol. 2026 Jun 15:jrheum.2025-1267. doi: 10.3899/jrheum.2025-1267.
    

    >> Share

    
    

    
    Kidney Int

28. FANOURIAKIS A, Teng YKO
    Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?
    Kidney Int. 2026;110:39-41.
    

    >> Share

    
    
29. BURBELO PD, Howard L, Caza TN, Borza DB, et al
    Quantitative Serological Detection of NELL1 Autoantibodies in Membranous Nephropathy.
    Kidney Int. 2026 Jun 18:S0085-2538(26)00497-7. doi: 10.1016/j.kint.2026.
    

    >> Share

    
    
30. BASSANESE G, Weingarten AM, Mancuso MC, Levart TK, et al
    Real-world outcomes of pegcetacoplan treatment in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis.
    Kidney Int. 2026 Jun 15:S0085-2538(26)00433-3. doi: 10.1016/j.kint.2026.
    

    >> Share

    
    

    
    Lancet Neurol

31. LUO W, Wei Z, Huang X, Du Y, et al
    Optic nerve involvement in multiple sclerosis diagnosis.
    Lancet Neurol. 2026;25:626.
    

    >> Share

    
    
32. SAIDHA S, Green AJ, Balcer L, Calabresi PA, et al
    Optic nerve involvement in multiple sclerosis diagnosis - Authors' reply.
    Lancet Neurol. 2026;25:627.
    

    >> Share

    
    
33. OH J, Bar-Or A, Montalban X, Sormani MP, et al
    Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.
    Lancet Neurol. 2026;25:673-688.
    

    >> Share

    
    

    
    Neurol Clin Pract

34. MOHAPATRA P, Chandu M, Kumar P, Singh RK, et al
    Long-Term Outcomes in Antibody-Negative Autoimmune Encephalitis: A Systematic Review and Meta-Analysis.
    Neurol Clin Pract. 2026;16:e200602.
    

    >> Share

    
    

    
    Neurology

35. BOS L, Wink AM, Cole JH, Pontillo G, et al
    Mediation Analysis Between Brain Age, Disease-Modifying Factors, and Disability and Cognitive Performance in Multiple Sclerosis.
    Neurology. 2026;107:e218161.
    

    >> Share

    
    
36. ALLEN JA, Eftimov F, Querol L, Sommer C, et al
    Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Neurology. 2026;107:e218159.
    

    >> Share

    
    
37. SCHARF A, Cohen JA, Marrie RA, Miller AE, et al
    Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.
    Neurology. 2026;107:e218183.
    

    >> Share

    
    
38. TINTORE M, Rovira A
    Redefining Multiple Sclerosis: Toward a Biologically Driven Diagnosis.
    Neurology. 2026;107:e218210.
    

    >> Share

    
    

    
    PLoS One

39. STAHL LS, Hickstein J, Kopke S, Hellwig K, et al
    Motherhood choice in multiple sclerosis (MoMS) - Pilot trial of web-based decision support.
    PLoS One. 2026;21:e0351108.
    

    >> Share

    
    
40. GIOVANNETTI AM, Giordano A, Donarelli E, Di Domenico G, et al
    Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure development.
    PLoS One. 2026;21:e0349034.
    

    >> Share

    
    

    
    Thyroid

41. RYMUZA J, Kus A, Nedeljkovic Beleslin B, Knezevic M, et al
    Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent Cohorts.
    Thyroid. 2026 May 12:10507256261450089. doi: 10.1177/10507256261450089.
    

    >> Share

    
    
42. LISHINSKY-FISCHER N, Pollack R, Gur Z
    Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort Study.
    Thyroid. 2026;36:665-673.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share